liraglutide 🐶 Veterinary Use | Indications/Contra | FAERs-F | FAERs-M | Orange Bk | BioActivity |

Stem definitionDrug idCAS RN
glucagon-like peptide (GLP) analogues and agonists 4164 204656-20-2

Description:

MoleculeDescription

Molfile Inchi Smiles

Synonyms:

  • saxenda
  • liraglutide [rDNA origin]
  • liraglutide rDNA origin
  • liraglutide [rNDA origin] injection
  • liraglutide
  • NN2211
  • victoza
  • liraglutide recombinant
An analog of GLUCAGON-LIKE PEPTIDE 1 and agonist of the GLUCAGON-LIKE PEPTIDE 1 RECEPTOR that is used as a HYPOGLYCEMIC AGENT and supplemental therapy in the treatment of DIABETES MELLITUS by patients who do not respond to METFORMIN.
  • Molecular weight: 3751.26
  • Formula: C172H265N43O51
  • CLOGP:
  • LIPINSKI: None
  • HAC: 94
  • HDO: 54
  • TPSA: 1513.76
  • ALOGS:
  • ROTB: 130

Drug dosage:

DoseUnitRoute
40 U P
1.50 mg P

ADMET properties:

Approvals:

FDA Adverse Event Reporting System (Female)

FDA Adverse Event Reporting System (Male)

FDA Adverse Event Reporting System (Geriatric)

FDA Adverse Event Reporting System (Pediatric)

None

Pharmacologic Action:

Drug Use | Suggest Off label Use Form| |View source of the data|




🐶 Veterinary Drug Use

None

🐶 Veterinary products

None

Acid dissociation constants calculated using MoKa v3.0.0

Orange Book patent data (new drug applications)

Orange Book exclusivity data (new drug applications)

Bioactivity Summary:

External reference:

Pharmaceutical products:

liraglutide